Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Net Cash Flow (2022 - 2025)

Bioregenx has reported Net Cash Flow over the past 4 years, most recently at $22436.0 for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 243.33% year-over-year to $22436.0; the TTM value through Dec 2025 reached $13013.0, up 118.6%, while the annual FY2025 figure was $13013.0, 118.6% up from the prior year.
  • Net Cash Flow for Q4 2025 was $22436.0 at Bioregenx, up from -$6731.0 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $68381.0 in Q4 2023 and troughed at -$239056.0 in Q2 2023.
  • A 4-year average of -$36920.4 and a median of -$9508.0 in 2024 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 8005.32% in 2023 and fell as far as 28655.33% in 2023.
  • Year by year, Net Cash Flow stood at -$865.0 in 2022, then soared by 8005.32% to $68381.0 in 2023, then crashed by 122.89% to -$15653.0 in 2024, then surged by 243.33% to $22436.0 in 2025.
  • Business Quant data shows Net Cash Flow for BRGX at $22436.0 in Q4 2025, -$6731.0 in Q3 2025, and -$29972.0 in Q2 2025.